Is Indogulf Cropsci overvalued or undervalued?
2025-11-14 08:13:51As of 13 November 2025, the valuation grade for Indogulf Cropsci has moved from very attractive to attractive. The company is currently fairly valued based on its financial metrics. Key ratios include a PE ratio of 20.31, an EV to EBIT of 15.67, and a ROE of 11.27%. In comparison to peers, Indogulf Cropsci's PE ratio is more favorable than Coromandel International's 30.53, while being higher than Chambal Fertilizers' 10.04. The company's recent stock performance has lagged behind the Sensex, with a 1-month return of -7.02% compared to the Sensex's 2.61%, reinforcing the notion that it is fairly valued in the current market environment....
Read full news articleHow has been the historical performance of Indogulf Cropsci?
2025-11-13 23:55:14Answer: The historical performance of Indogulf Cropsci shows a positive trend in key financial metrics over the past year. Breakdown: In the fiscal year ending March 2025, Indogulf Cropsci reported net sales of 590.42 crore, an increase from 552.23 crore in March 2024. The total operating income also rose to 590.42 crore, reflecting a similar growth pattern. However, the raw material costs increased significantly to 455.31 crore from 402.67 crore, while the purchase of finished goods decreased slightly. The total expenditure, excluding depreciation, was 526.13 crore, up from 492.82 crore, leading to an operating profit (PBDIT) of 68.34 crore, which was higher than the previous year's 62.96 crore. Profit before tax improved to 44.57 crore from 36.04 crore, resulting in a profit after tax of 31.47 crore compared to 28.23 crore in the prior year. The earnings per share also saw a rise to 6.45 from 6.00. On th...
Read full news articleAnnouncement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation
07-Feb-2026 | Source : BSEEarnings Conference Call for Q3 FY 2025-26
Board Meeting Intimation for Prior Intimation Of Board Meeting
06-Feb-2026 | Source : BSEIndogulf Cropsciences Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 11/02/2026 inter alia to consider and approve This is to inform you that the Board Meeting of the company is scheduled to be held on Wednesday the 11th day of February 2026 to consider and approve the un-audited quarterly financial results for the Quarter ended 31st December 2025
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation
16-Jan-2026 | Source : BSEIntimation of Re-scheduling of Investor Meet
Corporate Actions
(11 Feb 2026)
No Dividend history available
No Splits history available
No Bonus history available
No Rights history available






